Background: Ischemic stroke (IS) became the most common type of stroke in 2021, leading to an extreme health burden globally, and has the potential to further increase the burden in the young. However, current therapies for IS are limited, and its mechanism remains unclear. Methods: SPF C57BL/6J male mice were used to establish the middle cerebral artery occlusion (MCAO) model. The Longa’s Neurological Deficit Score and TTC staining served as evaluative metrics for the efficacy of the model. Untargeted metabolomics analysis was performed based on LC-MS technology, and PCA, PLS-DA, and KEGG analysis were used to explore the differential metabolites. Results: Compared to the Sham group, the neurological deficit score of the MCAO group was significantly higher at 2 h and 72 h after surgery (p < 0.001). There was no infarct volume in the Sham group, while the infarct volume ratio of the MCAO group significantly increased compared with that of the Sham group. In total, 1836 metabolites were identified overall, and they were clustered into 14 classifications, with “lipids and lipid-like molecules” accounting for the most (34.45%). Compared with the Sham group, 95 metabolites were up-regulated, and 107 metabolites were down-regulated in the MCAO group; 138 of 202 were identified with HMDB numbers. A further clustering and KEGG pathway analysis showed that these 138 metabolites may be involved in lipid metabolism, amino acid metabolism, and nucleotide metabolism. However, FDR was not used as extracting criteria to screen out the differential metabolites, which indicated that the outcomes should be considered for further validation. Conclusions: This discovery-stage untargeted metabolomics analysis suggests that ischemic stroke may be associated with alterations in lipid, amino acid, and nucleotide metabolism in the mouse brain, but these exploratory findings require validation in larger independent cohorts using targeted metabolomics.

OBJECTIVE:This study aims to investigate the role of FTO-mediated m6A modification in the promotion of angiogenesis by electroacupuncture (EA) after ischemic stroke via the miR-214/EZH2/eNOS signaling axis. METHOD:Adult male Sprague-Dawley rats were subjected to a Middle Cerebral Artery Occlusion (MCAO) model to simulate ischemic stroke. EA was applied at the Shuigou acupoint (GV26). Neurological deficits scores, 2,3,5-triphenyltetrazolium chloride staining, and hematoxylin-eosin staining were conducted to evaluate the pathological changes. Angiogenesis was assessed via CD31 and Ki67 immunofluorescence staining. The RNA and protein expression levels of key factors were measured by RT-qPCR and Western Blot. To verify the signaling pathway, an FTO inhibitor and a miR-214-3p antagonist were administered via lateral ventricle injection. RESULT:EA treatment significantly improved neurological deficits, reduced cerebral infarct volume, alleviated pathological damage, and promoted angiogenesis after ischemic stroke. MCAO resulted in decreased expression of miR-214-3p, eNOS mRNA, and eNOS protein. These alterations were effectively reversed by EA intervention. The therapeutic benefits of EA were blocked by miR-214 antagomir. Furthermore, the MCAO-induced downregulation of FTO mRNA and protein was restored by EA, and the effect was abolished by the FTO inhibitor. The FTO inhibitor also prevented the EA effects on the miR-214/EZH2/eNOS axis. DISCUSSION:Based on previous experimental studies and the established role of eNOS in angiogenesis, this section discusses the experimental findings on the regulation of m6A-mediated methylation of miR-214. CONCLUSION:EA promotes angiogenesis and improves functional recovery after ischemic stroke by regulating miR-214/EZH2/eNOS signaling axis through an FTO-dependent m6A modification. The study provides experimental evidence supporting EA as an effective therapy for ischemic stroke.

Background: With the global recognition of Traditional Chinese Medicine (TCM), acupuncture has gained widespread acceptance. However, training and assessing procedural skills in acupuncture, particularly for international students, remain challenging. The Direct Observation of Procedural Skills (DOPS) is a clinical assessment tool that provides real-time feedback, offering a potential solution to enhance practical skill development.Objective: This study evaluates the effectiveness of DOPS in improving practical skills, clinical thinking, and overall teaching quality among international acupuncture students.Methods: The study was conducted at the School of Acupuncture-Moxibustion and Tuina, Shanghai University of Traditional Chinese Medicine. A DOPS-based assessment scale was developed following the Technical Benchmark of Acupuncture and Moxibustion: Filiform Needle (2023). DOPS was applied through a three-stage process (preparation, operation, and feedback) to assess acupuncture preparation, needle insertion, manipulation, and disinfection. Feedback addressed deficiencies to enhance learning outcomes.Results: DOPS significantly improved international students' practical skills, operational proficiency, and critical thinking. Teachers and students reported high satisfaction with the system, which also facilitated the integration of theory with practice. Students refined their clinical skills and excelled in national competitions.Conclusions: DOPS is an effective tool for acupuncture skills training, providing standardized, real-time feedback that enhances teaching quality and bridges gaps in clinical practice. Future advancements, such as virtual reality and artificial intelligence, could further optimize the system and advance international acupuncture education.

To evaluate the effect and safety of Chinese medicine (CM) Fuzheng Huazhuo Decoction (FHD) in treating patients with coronavirus disease 2019 (COVID-19) who persistently tested positive for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). This retrospective cohort study was conducted at Shanghai New International Expo Center shelter hospital in China between April 1 and May 30, 2022. Patients diagnosed as COVID-19 with persistently positive SARS-CoV-2 reverse transcription-polymerase chain reaction (RT-PCR) test results for ⩾8 days after diagnosis were enrolled. Patients in the control group received conventional Western medicine (WM) treatment, while those in the FHD group received conventional WM plus FHD for at least 3 days. The primary outcome was viral clearance time. Secondary outcomes included negative conversion rate within 14 days, length of hospital stay, cycle threshold (Ct) values of the open reading frame 1ab (ORF1ab) and nucleocapsid protein (N) genes, and incidence of new-onset symptoms during hospitalization. Adverse events (AEs) that occurred during the study period were recorded. A total of 1,765 eligible patients were enrolled in this study (546 in the FHD group and 1,219 in the control group). Compared with the control group, patients receiving FHD treatment showed shorter viral clearance time for nucleic acids [hazard ratio (HR): 1.500, 95

Electroacupuncture (EA) has been widely used for the treatment of ischemic brain injury. Long noncoding RNAs (lncRNAs) have been confirmed to participate in the pathophysiological progression of various neurological disorders. However, the mechanism by which EA regulates the expression and functions of lncRNAs in ischemic brain injury is still unclear. In the present study, middle cerebral artery occlusion (MCAO) rats were treated with EA. The infarct volume and neurological deficit score were assessed to evaluate the therapeutic effect of EA. RNA sequencing (RNA-Seq) was used to obtain mRNA and lncRNA profiles, which were validated via qRT‒PCR. A total of 2198 lncRNAs and 3919 mRNAs were identified as DE genes in MCAO rats compared with sham rats, and 602 lncRNAs and 180 mRNAs were identified as remarkably DE genes in MCAO rats after EA treatment compared with MCAO rats. Bioinformatic analysis was performed on the identified deregulated genes through gene ontology (GO) analysis and Kyoto Encyclopedia of Genes and Genomes (KEGG) pathway analysis. Pathway analysis revealed that inflammation-related signaling pathways (the p53 signaling pathway, TNF signaling pathway and MAPK signaling pathway) play vital roles in the treatment of EA. Fluorescence in situ hybridization (FISH) and dual-luciferase reporter gene, qRT‒PCR and western blot analyses revealed that the lncRNA NONRATT016536.2 sponged miR-665 to regulate the inflammatory response by targeting FCRL2. Our study suggested that EA treatment effectively improved ischemic brain injury. Bioinformatics analysis of the lncRNAs and mRNAs profiles of MCAO rats provides a new perspective on the neuroprotective effects of EA.

Sepsis is a severe systemic inflammatory response syndrome in which matrix metalloproteinase 9 (MMP9) plays a key role in inflammatory response and cell migration. In this study, we analyzed different sepsis phenotypes to explore the role of MMP9 in promoting the progression of sepsis, especially how it affects the inflammatory index and related pathogenic cell programs. A standardized cecal ligation puncture (CLP) model was used to evaluate the inflammatory response in sepsis. The experiments followed animal ethical principles and extracted proteins and performed SDS-PAGE analysis for mass spectrometry identification. The samples were separated using filter-assisted sample preparation (FASP) and peptide digestion techniques, and the peptides were separated by ultra-high performance liquid chromatography (UHPLC). Subsequently, proteomic analysis, RNA extraction and differential expression analysis were performed on the data, and bioinformatics and machine learning methods were combined to evaluate the inflammatory index of both in vivo and in vitro samples. Through the integration of admission parameters, different sepsis endotypes and their clinical phenotypes were identified. Significantly, elevated MMP9 expression was found to be strongly associated with inflammatory indices such as NLR and PLR in patients with sepsis, suggesting that MMP9 may be involved in the proliferation of immune cells and the activation of their pro-inflammatory and hypoxic programs. Experimental CLP models validate the pathogenic cellular programs associated with NLR and PLR, demonstrating the critical role of MMP9 in the dynamic progression of sepsis.

To observe the angiogenesis effect of electroacupuncture (EA) at Shuigou acupoint (GV 26) in the treatment of cerebral ischemia, and explore the value of miRNA-7 (miR-7) in it. First, 48 mice were randomly divided into sham operation, middle cerebral artery occlusion (MCAO) model, and EA treatment groups. Then 9 mice were divided into carrier control group, miR-7 knockout group and miR-7 overexpression group (n=3 each group). Finally, 20 mice were divided into model and carrier control group, model and miR-7 knockout group, EA treatment and carrier control group and EA treatment and miR-7 overexpression group, with 3–6 mice in each group. The MCAO model was established in the MCAO and EA groups. Neurological deficit score and 2,3,5-triphenyltetrazolium chloride (TTC) staining were used to evaluate the severity of cerebral ischemia. Hematoxylin-eosin staining was used to describe basic pathological changes. Immunohistochemistry was used to quantify cerebral microvessel density. Real-time PCR and Western blot were used to detect the expression of miR-7 and its downstream target genes Krüppel-like factor 4/vascular endothelial growth factor (KLF4/VEGF) and angiopoietin-2 (ANG-2) in the ischemic cerebral cortex. After EA, neurological deficit scores and infarction volumes decreased, and the density of cerebral microvessels increased. In the MCAO group, miR-7 expression was higher than that in the sham group (P<0.01). After EA at GV 26, miR-7 expression decreased (P<0.01) and the expression of downstream target genes KLF4/VEGF and ANG-2 increased as compared with the MCAO group (P<0.01). After EA combined with overexpression of miR-7, the expression of downstream target genes KLF4/VEGF and ANG-2 decreased compared to the control EA group (P<0.01). After miR-7 knockdown, the expression of KLF4/VEGF and ANG-2 increased (P<0.05 or P<0.01). EA could promote angiogenesis in MCAO mice likely by inhibiting the expression of miR-7 and relieving inhibition of downstream target genes KLF4/VEGF and ANG-2.

The persistence of neuronal degeneration and damage is a major obstacle in ageing medicine. Nucleotide-binding oligomerization domain (NOD)-like receptors detect environmental stressors and trigger the maturation and secretion of pro-inflammatory cytokines that can cause neuronal damage and accelerate cell death. NLR (NOD-like receptors) inflammasomes are protein complexes that contain NOD-like receptors. Studying the role of NLR inflammasomes in ageing-related neurological disorders can provide valuable insights into the mechanisms of neurodegeneration. This includes investigating their activation of inflammasomes, transcription, and capacity to promote or inhibit inflammatory signaling, as well as exploring strategies to regulate NLR inflammasomes levels. This review summarizes the use of NLR inflammasomes in guiding neuronal degeneration and injury during the ageing process, covering several neurological disorders such as Alzheimer's disease, Parkinson's disease, amyotrophic lateral sclerosis, stroke, and peripheral neuropathies. To improve the quality of life and slow the progression of neurological damage, NLR-based treatment strategies, including inhibitor-related therapies and physical therapy, are presented. Additionally, important connections between age-related neurological disorders and NLR inflammasomes are highlighted to guide future research and facilitate the development of new treatment options.

BACKGROUND AND PURPOSE:Electroacupuncture (EA) is one of the non-pharmacological therapies in traditional Chinese medicine to treat urinary retention. The objective of this meta-analysis is to assess the efficacy of electroacupuncture in the treatment of urinary retention after stroke. METHODS:Overall, seven electronic databases were searched until December 31, 2023, and randomized control trials about EA for urinary retention after stroke were reviewed. Two reviewers independently screened the literature, extracted the data, and assessed the risk of bias for included studies. The meta-analysis was conducted by RevMan 5.4 and Stata/MP 17.0 software. RESULTS:Eleven studies with a total of 856 participants were included in this meta-analysis. EA treatment yielded an improved reduction in the post-void residual (PVR) (mean difference [MD]: 37.85, 95 % confidence interval [CI]: 55.09 to -20.61 p < 0.0001) and the weight of diaper pads (MD: 38.87, 95 % CI: 42.68 to -335.06). Further analysis indicated that EA improved the effectiveness ratio (risk ratio [RR]: 1.36, 95 % CI: 1.20 to 1.53, p < 0.00001), the function of the bladder (MD: 0.45, 95 % CI: 0.61 to -0.30), and the quality of life (MD: 1.15, 95 %: CI: 2.10 to -0.20) in comparison to normal treatment and simple acupuncture. CONCLUSION:EA may be an effective way and reasonable modality to incorporate into the multiple prevention and therapy for urinary retention after stroke. The wide application of EA could be associated with the improvement of bladder and life quality and decline in the PVR for patients after stroke with urinary retention.

OBJECTIVES:To observe the effect of electroacupuncture on miR-142-5p and ADAMTS1/PI3K/AKT pathway in rats with ischemic stroke, so as to explore the regulatory mechanism of electroacupuncture on angiogenesis after ischemic stroke. METHODS:This study was divided into two parts. The first part of the experiment：SD rats were randomly divided into sham operation group, model group and electroacupuncture group. There were 20 rats in each group. The middle cerebral artery occlusion (MCAO) rat model was prepared using a modified Longa's method. In the electroacupuncture group, "Shuigou" (GV26) was selected for electroacupuncture intervention (4 Hz/20 Hz) for 30 min each time. The rats in the electroacupuncture group were given electroacupuncture immediately after successful modeling, once a day for 4 times. Hunter score and TTC staining were used to observe the neurological deficits and infarct volumes respectively；HE staining was used to observe the cortical pathological changes；immunohistochemistry was used to determine the changes of cerebral microvascular density. Real-time quantitative PCR and Western blot were used to observe the miR-142-5p expression, mRNA and protein expression levels of ADAMTS1, VEGF, PI3K, AKT, eNOS in ischemic cortex. The second part of the experiment：The rats were randomly divided into electroacupuncture+control group and electroacupuncture+miR-142-5p Antagomir group with 8 rats in each group. MCAO model was established after injection. Electroacupuncture+control group was given 0.9% sodium chloride solution injected into the right ventricle.The rats in the electroacupuncture+miR-142-5p Antagomir group were injected with miR-142-5p inhibitor into the right ventricle 30 min before modeling. Rats in electroacupuncture+control group and electroacupuncture+miR-142-5p Antagomir group were all given the same electroacupuncture treatment. Real-time fluorescence quantitative PCR was used to observe the effect of miR-142-5p Antagomir on the expression of miR-142-5p and ADAMTS1 mRNA. The effect of miR-142-5p Antagomir on ADAMTS1 protein was observed by Western blot. RESULTS:In the first part of the experiment, compared with the sham operation group, the Hunter score in the model group was significantly increased (P<0.01)；the volume of cerebral infarction in the model group was significantly increased (P<0.01)；the degree of brain edema and neuronal necrosis and the density of cerebral microvessels was increased；the cerebral microvascular density was significantly increased (P<0.01)；the expression levels of miR-142-5p and the mRNA expression levels of VEGF, AKT and eNOS were significantly decreased (P<0.01, P<0.05), and the protein expression levels of VEGF, p-AKT and eNOS were significantly down-regulated (P<0.01), while the mRNA expression levels of ADAMTS1 and PI3K, and the protein expression levels of ADAMTS1 and p-PI3K were all up-regulated (P<0.01, P<0.05) in the model group. Compared with the model group, after intervention, the Hunter score in the electroacupuncture group was decreased (P<0.01), the volume of cerebral infarction was significantly decreased (P<0.01)；the degree of brain edema and neuronal necrosis were alleviated；the cerebral microvascular density was significantly increased (P<0.01)；the expression of miR-142-5p and the mRNA expression of VEGF, PI3K, AKT and eNOS were increased (P<0.01), the protein expressions of VEGF, p-PI3K, p-AKT and eNOS were increased (P<0.01, P<0.05), while the mRNA and protein expression of ADAMTS1 were decreased (P<0.05, P<0.01). After injection of miR-142-5p inhibitor, compared with electroacupuncture+control group, the expression of miR-142-5p in electroacupuncture+miR-142-5p Antagomir group was decreased(P<0.05), while the mRNA and protein expression of ADAMTS1 were increased (P<0.01, P<0.05). CONCLUSIONS:Electroacupuncture at GV26 can improve the neurological damage of ischemic stroke rats, reduce the volume of cerebral infarction and promote angiogenesis. The mechanism may be associated with the function of electroacupuncture in promoting the expression of miR-142-5p, so as to inhibit the expression of its target gene ADAMTS1, mediate the up-regulation of VEGF expression, activate PI3K/AKT pathway, promote the release of eNOS, and participate in promoting angiogenesis in ischemic stroke rats.

Importance: The global COVID-19 pandemic does not appear to end in the near future. Currently, limited data are available on the risk factors for delayed viral clearance in patients with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) Omicron variant infection. Objective: This study aimed to investigate the association of clinical characteristics and vaccination with prolonged viral clearance. Methods: This retrospective cohort included 16,985 patients who had contracted the SARS-CoV-2 Omicron variant between April 5 and May 30, 2022, in Shanghai, China, and had mild or no symptoms. The patients were admitted to the quarantine venue at the Shanghai New International Expo Center. Results: Of the 16,985 participants, the occurrence of viral clearance was ≤8 and > 8 days in 11,009 (64.8 %) and 5976 (35.2 %) participants, respectively. Risk factors related to patients who remained persistently polymerase chain reaction (PCR)-positive were sex (Male, odds ratio [OR] 1.221, p < 0.001), older age (35–49, OR 1.389, p < 0.001; 50–64, OR 1.659, p < 0.001; ≥65, OR 2.139, p < 0.001), presence of symptoms (OR 1.093, p = 0.030), number of vaccinations (two doses, OR 0.753, p < 0.001; three doses, OR 0.797, p < 0.001; four doses, OR 0.543, p < 0.001), and cycle threshold (Ct) value for ORF1ab gene at diagnosis (25–35, OR 0.235, p < 0.001; >35, OR 0.079, p < 0.001). The lower rates of increase in Ct values were observed in the later viral shedding group than in the early viral shedding group for ORF1ab (β = −0.791, p < 0.001) and N genes (β = −0.825, p < 0.001). Conclusion: Prolonged SARS-CoV-2 RNA detection and higher viral concentrations were associated with factors such as male sex, older age, symptomatic status, and fewer doses of vaccination in patients admitted to Shanghai Makeshift Hospital between April 5 and May 30, 2022.

Background: Lianhua Qingwen Granules or Capsules (LHQW) has accumulated much research evidence in the fight against the coronavirus disease 2019 (COVID-19) epidemic. However, there are still few data on its efficacy and safety in children with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection. Purpose: To evaluate the efficacy and safety of LHQW in children with SARS-CoV-2 Omicron infection. Methods: We conducted a single-center, propensity-score matched retrospective cohort study of children with SARS-CoV-2 Omicron infection in Shanghai New International Expo Center mobile cabin hospital between April 1st and June 1st, 2022. Eligible patients received either LHQW granules/capsules plus supportive care (LHQW group) or supportive care alone (control group). The primary outcome was the negative conversion time of nucleic acid. Secondary outcomes included the negative conversion rate of nucleic acid, the length of hospital stay, clinical disease progression, and cycle threshold [Ct] values for SARS-CoV-2 open reading frame [ORF1ab] or nucleocapsid [N] genes. Results: Overall, 2808 patients were enrolled, and 346 patients in each group were included in the analysis. Among the propensity-score matched groups, LHQW treatment was associated with an accelerated negative conversion time of nucleic acid (median: 5 d vs. 6 d, Hazard ratio: 1.25, 95% CI: 1.08 - 1.46, Log-rank p < 0.001), a higher negative conversion rate of nucleic acid (Day 2 - 6: 2.9% vs. 0.6%, p = 0.036; 29.8% vs. 5.5%, p < 0.001; 42.5% vs. 24.3%, p < 0.001; 51.4% vs. 31.5%, p < 0.001; 63.3% vs. 55.2%, p = 0.030), shorter hospital stay (median: 10 d vs. 11 d, Hazard ratio: 1.50, 95% CI: 1.29 - 1.74, Log-rank p < 0.001), and lower rates of asymptomatic infection progressing to mild (37.9% vs. 46.5%, p = 0.021). Conclusion: Our study suggested that LHQW treatment was associated with faster clinical recovery in children with SARS-CoV-2 Omicron infection.

Objective: Reyanning mixture has been demonstrated to be effective in treating infected patients during the outbreak pandemic of SARS-CoV-2 Omicron variant of Coronavirus disease 2019 (COVID-19) in Shanghai 2022. The aim of this study is to further investigate the role of Reyanning mixture specifically in the treatment of elderly patients. Methods: This study enrolled 1,102 elderly patients who were infected with SARSCoV-2 Omicron variant. Of these, 291 patients received Reyanning mixture in conjunction with conventional Western medicine treatment were assigned to the treatment group, while 811 patients only received conventional Western medicine treatment were assigned to the control group. Clinical parameters including hospitalization duration, viral shedding time, and Cycle Threshold (Ct) values of novel coronavirus nucleic acid tests, as well as adverse events were recorded and analyzed in both groups. Results: There was no significant difference in baseline characteristics between two groups. In comparison to the control group, the treatment group demonstrated a substantial difference in hospitalization duration (median: 8 days vs. 10 days, HR: 0.638, 95% CI: 0.558-0.731, p < 0.001). The treatment group also showed a significantly shorter viral shedding time compared to the control group (median: 7 days vs. 8 days, HR: 0.754, 95% CI: 0.659-0.863, p < 0.001). Multivariate Cox proportional-hazards model analysis indicated that the use of Reyanning mixture was closely associated with a reduction in hospitalization duration (HR: 1.562, 95% CI: 1.364-1.789, p < 0.001) and viral shedding time (HR: 1.335, 95% CI: 1.166-1.528, p < 0.001). In addition, during the treatment process, no serious adverse event occurred in either group. Conclusion: The improvement of clinical parameters in the treatment group indicate a promising therapeutic benefit of Reyanning mixture for elderly patients infected with SARS-CoV-2 Omicron variant in the present study. Further investigations are required to validate this finding by examining the underlying mechanism and function of Reyanning mixture.

Objective: To evaluate the prognostic ability of systemic immune-inflammation index (SII) combine with quick Sequential Organ Failure Assessment (qSOFA) criteria in predicting the 28day mortality of sepsis.Methods: A retrospective cohort study was conducted, with the population comprised in whom sepsis was confirmed. Clinical and laboratory data recorded were analyzed. The score of Sequential Organ Failure Assessment (SOFA), SII, qSOFA were calculated. Multivariable regression, receiver operating characteristic (ROC) analysis and Kaplan-Meier method were used to identify and compared the predictors of prognosis among SOFA, qSOFA, and the combination of SII with qSOFA.Results: A total of 349 patients admitted from December 2020 and December 2022 were included in the cohort. 95 (27.2%) of whom had died by day 28. The SII, SOFA, and qSOFA scores were significant higher in the non-survivors than that of survivors (P < 0.05), and identified as independent predictors of sepsis mortality. The addition of SII to qSOFA shown an area under receiver operator characteristic (AUROC) of 0.840 (95% CI: 0.787-0.884), manifested an effective ability in predicting poor outcome than other scoring systems. The optimum cutoff for SII (>1.7668) and qSOFA (>1) represented a high risk level in 28-day mortality of sepsis, were performed and identified in Kaplan-Meier survival curves (log-rank test, HR: 6.942, 95% CI: 3.976-12.121; P < 0.0001).Conclusion: The SII in addition to qSOFA provided an effective prognostic tool for predicting mortality in sepsis.

缺血性脑卒中指脑血循环障碍导致脑血管堵塞或严重狭窄,使脑血流灌注下降,进而缺血、缺氧导致脑血管供血区脑组织死亡,已成为全球第二大致死原因.缺血性脑卒中及其后遗症对病人身心健康造成危害,故对缺血性脑卒中的治疗问题亟待解决.非编码RNA在中医药诊治机制中发挥着重要作用.通过文献整理的方法综述中医药调控非编码RNA干预缺血性脑卒中机制的研究进展,旨在为临床对缺血性脑卒中的诊断、辨证论治、治疗方案拟定、新药研发等提供参考.

The endovascular intervention technique has gained prominence in the treatment of intracranial aneurysms due to its minimal invasiveness and shorter recovery time. A critical step of the intervention is the shaping of the microcatheter, which ensures its accurate placement and stability within the aneurysm sac. This is vital for enhancing coil placement and minimizing the risk of catheter kickback during the coiling process. Currently, microcatheter shaping is primarily reliant on the operator's experience, who shapes them based on the curvature of the target vessel and aneurysm location, utilizing 3D rotational angiography or CT angiography. Some researchers have documented their experiences with conventional shaping methods. Additionally, some scholars have explored auxiliary techniques such as 3D printing and computer simulations to facilitate microcatheter shaping. However, the shaping of microcatheters can still pose challenges, especially in cases with complex anatomical structures or very small aneurysms, and even experienced operators may encounter difficulties, and there has been a lack of a holistic summary of microcatheter shaping techniques in the literature. In this article, we present a review of the literature from 1994 to 2023 on microcatheter shaping techniques in endovascular aneurysm embolization. Our review aims to present a thorough overview of the various experiences and techniques shared by researchers over the last 3 decades, provides an analysis of shaping methods, and serves as an invaluable resource for both novice and experienced practitioners, highlighting the significance of understanding and mastering this technique for successful endovascular intervention in intracranial aneurysms.

Background:Sepsis is a life-threatening disease with high mortality and a poor prognosis,partly due to a lack of effective treatments.Therefore,more effective treatments are urgently needed.Methods:Eight databases were searched for use of traditional Chinese medicine（TCM） for sepsis.A meta-analysis was performed using Stata 15.0 software.The 28-day mortality,length of hospital stay,and Acute Physiology and Chronic Health Evaluation Ⅱ（APACHE-Ⅱ） score were the outcomes of this study.The Cochrane Collaboration tool for assessing risk of bias was used for quality assessment.Results:Ten studies with a total of 847 patients were included in this meta-analysis.Compared with the control group,the experimental group had lower 28-day mortality（relative risk [RR] 0.67;95% confidence interval [CI] 0.53 to 0.84;P=0.001）,shorter hospital stay（weighted mean difference [WMD]-2.17;95% CI:-3.2 to -1.14;P=0.000） and lower APACHE-Ⅱ score（WMD-2.164;95% CI:-3.236 to -1.091;P=0.000）.Conclusion:Our results demonstrate that TCM together with standard Western medicine was associated with significantly lower 28-day mortality,APACHE Ⅱ scores,and shorter hospital intensive care unit stays,suggesting that TCM might be an effective alternative treatment for sepsis.